| COMPANY | SYMBOL | TYPE | PRICE | Shares | Trade Date | UNDERWRITER (S) |
| AC Immune SA | ACIU | IPO | $11.00-$13.00 | 6 million | 9/23/2016 | Credit Suisse, Jefferies, Leerink Partners |
| AdaptImmune Therapeutics | ADAP | IPO | $15.00-$17.00 | 11.25 million | 5/6/2015 | BofA Merrill Lynch, Cowen & Co., Leerink Partners
|
| Aduro Biotech | ADRO | IPO | $14.00-$16.00 | 7 million | 4/15/2015 | BofA Merrill Lynch, Leerink Partners |
| Affimed Therapeutics B.V. | AFMD | IPO | $11.00-$13.00 | 8 million | 9/12/2014 | Jefferies, Leerink Partners BMO Capital Markets |
| AgomAb Therapeutics NV | AGMB | IPO | $15.00-$17.00 | 12.5 million | 2/6/2026 | J.P. Morgan, Morgan Stanley, Leerink Partners, Van Lanschot Kempen |
| Aktis Oncology, Inc. | AKTS | IPO | $16.00-$18.00 | 17.65 million | 1/9/2026 | J.P. Morgan, BofA Securities, Leerink Partners, TD Cowen |
| Alamar Biosciences, Inc. | ALMR | IPO | $15.00-$17.00 | 11.25 million | 4/17/2026 | J.P. Morgan, BofA Securities, TD Cowen, Leerink Partners, Stifel |
| Alder Biopharmaceuticals | ALDR | IPO | $13.00-$15.00 | 7.15 million | 5/8/2014 | Credit Suisse, Leerink Partners. |
| Alumis Inc. | ALMS | IPO | $16.00-$18.00 | 13.125 million | 6/28/2024 | Morgan Stanley, Leerink Partners, Cantor, Guggenheim Securities |
| Aptinyx, Inc. | APTX | IPO | $14.00-$16.00 | 6.4 million | 6/21/2018 | J.P. Morgan, Cowen, Leerink Partners, BMO Capital Markets |
| Arcus Biosciences, Inc. | RCUS | IPO | $13.00-$15.00 | 8 million | 3/15/2018 | Citigroup, Goldman Sachs & Co., Leerink Partners |
| Ardelyx Inc., | ARDX | IPO | $13.00-$15.00 | 4.3 million | 6/19/2014 | Citigroup, Leerink Partners |
| Ardent Health Partners, Inc. | ARDT | IPO | $20.00-$22.00 | 12 million | 7/18/2024 | J.P. Morgan, BofA Securities, Morgan Stanley, Stephens Inc, Citigroup, Leerink Partners, RBC Capital Markets, Truist Securities, Mizuho, Capital One Securities, Loop Capital Markets |
| Asante Solutions, Inc. | PUMP | IPO | $13.00-$15.00 | 3.5 million | 0/0/0 | Leerink Partners, Cowen and Company
|
| Ascendis Pharma A/S | ASND | IPO | $16.00-$18.00 | 6 million | 1/28/2015 | BofA Merrill Lynch, Leerink Partners, Wells Fargo Securities |
| ASLAN Pharmaceuticals Limited | ASLN | IPO | $8.05-$8.05 | 6 million ADSs | 5/4/2018 | Leerink Partners, Piper Jaffray |
| Aspen Neuroscience Inc. | ASPE | IPO | TBD | TBD | 0/0/0 | Leerink Partners, Piper Sandler, Stifel, UBS Investment Bank, Oppenheimer & Co. |
| Attovia Therapeutics, Inc. | ATTO | IPO | $17.00-$17.00 | 17 million | 8/5/2026 | Morgan Stanley, Leerink Partners, Citigroup, RBC Capital Markets, LifeSci Capital |
| Auris Medical Holding AG | EARS | IPO | $10.00-$12.00 | 9.4 million | 8/6/2014 | Jefferies, Leerink Partners |
| Bellerophon Therapeutics | BLPH | IPO | $14.00-$16.00 | 4 million | 2/13/2015 | Leerink Partners, Cowen & Co. |
| Beta Bionic, Inc. | BBNX | IPO | $16.00-$17.00 | 12 million | 1/30/2025 | BofA Securities, Piper Sandler, Leerink Partners |
| BlossomHill Therapeutics, Inc. | BLSM | IPO | $15.00-$17.00 | 9.375 million | 8/7/2026 | J.P. Morgan, Leerink Partners, Guggenheim Securities, LifeSci Capital, H.C. Wainwright |
| Boundless Bio Inc | BOLD | IPO | $15.00-$17.00 | 6.25 million | 3/28/2024 | Goldman Sachs, Leerink Partners, Piper Sandler, Guggenheim Securities |
| BrightSpring Health Services, Inc. | BTSG | IPO | $15.00-$18.00 | 53.3 million | 1/26/2024 | Goldman Sachs, KKR, Jefferies, Morgan Stanley, UBS, BofA Securities, Leerink Partners, Wells Fargo, Deutsche Bank, HSBC, Mizuho, BMO Capital Markets, Loop Capital Markets |
| Calithera Biosciences | CALA | IPO | $13.00-$15.00 | 8 million | 10/2/2014 | Citigroup, Leerink Partners |
| CAMP4 Therapeutics Corporation | CAMP | IPO | $14.00-$16.00 | 6.82 million | 10/11/2024 | J.P. Morgan, Leerink Partners, Piper Sandler, William Blair
|
| Carbylan Therapeutics | CBYL | IPO | $12.00-$14.00 | 13 million | 4/9/2015 | Leerink Partners |
| CareDx Inc., | CDNA | IPO | $15.00-$17.00 | 4 million | 7/17/2014 | Piper Jaffray, Leerink Partners |
| Centrexion Therapeutics Corporation | CNTX | IPO | Postponed | Postponed | 0/0/0 | BofA Merrill Lynch, Leerink Partners, Evercore ISI |
| Cerulean Pharma | CERU | IPO | $11.00-$13.00 | 8.5 million | 4/10/2014 | Leerink Partners |
| Cidara Therapeutics | CDTX | IPO | $14.00-$16.00 | 4.8 million | 4/15/2015 | Jefferies, Leerink Partners |
| Clementia Pharmaceuticals | CMTA | IPO | $13.00-$15.00 | 8 million | 8/2/2017 | Morgan Stanley, Leerink Partners |
| Corium International, Inc. | CORI | IPO | $10.00-$12.00 | 6.5 million | 4/3/2014 | Jefferies, Leerink Partners |
| Crinetics Pharmaceuticals, Inc. | CRNX | IPO | $15.00-$17.00 | 6.0 million | 7/18/2018 | J.P. Morgan, Leerink Partners, Piper Jaffray |
| Dermira, Inc. | DERM | IPO | $14.00-$16.00 | 7.8 million | 10/3/2014 | Citigroup, Leerink Partners
|
| Dova Pharmaceuticals, Inc. | DOVA | IPO | $15.00-$17.00 | 4.41 million | 6/29/2017 | J.P. Morgan, Jefferies, Leerink Partners |
| Edge Therapeutics | EDGE | IPO | $14.00-$16.00 | 7.3 million | 10/1/2015 | Leerink Partners, Credit Suisse |
| Evommune, Inc. | EVMN | IPO | $15.00-$17.00 | 9.375 million | 11/6/2025 | Morgan Stanley, Leerink Partners, Evercore ISI, Cantor
|
| Exagen Diagnostics, Inc. | EXDX | IPO | TBD | TBD | 0/0/0 | Leerink Partners, Baird |
| FibroGen, Inc. | FGEN | IPO | $16.00-$19.00 | 8.1 million | 11/14/2014 | Goldman Sachs & Co., Citigroup, Leerink Partners
|
| Fireman B.V. | IFRX | IPO | $14.00-$16.00 | 6.67 million | 11/8/2017 | J.P. Morgan, Leerink Partners, BMO Capital Markets |
| Forward Pharma | FWP | IPO | $20.00-$22.00 | 10.5 million | 10/15/2014 | Leerink Partners, Jefferies, RBC Capital Markets
|
| HTG Molecular Diagnostics | HTGM | IPO | $13.00-$15.00 | 3.6 million | 5/6/2015 | Leerink Partners |
| Immune Design Corp | IMDZ | IPO | $12.00-$14.00 | 5 million | 7/24/2014 | Jefferies, Leerink Partners, Wells Fargo Securities |
| Intellia Therapeutics | NTLA | IPO | Priced at $18.00 | 6 million | 5/6/2016 | Credit Suisse, Jefferies, Leerink Partners |
| Invuity, Inc. | IVTY | IPO | $14.00-$16.00 | 4 million | 6/15/2015 | Piper Jaffray, Leerink Partners, Stifel |
| Iterum Therapeutics plc | ITRM | IPO | $14.00-$16.00 | 6.2 million | 5/25/2018 | Leerink Partners, RBC Capital Partners |
| Kailera Therapeutics, Inc. | KLRA | IPO | $14.00-$16.00 | 39.1 million | 4/17/2026 | J.P. Morgan, Leerink Partners, TD Cowen, Evercore ISI |
| Kardigan Inc. | KARD | IPO | $14.00-$16.00 | 23.3 million | 6/18/2026 | J.P. Morgan, Jefferies, Leerink Partners, TD Cowen |
| Karyopharm Therapeutics | KPTI | IPO | $14.00-$16.00 | 5.7 million | 11/6/2013 | BofA Merrill Lynch, J.P. Morgan, Leerink Partners |
| Kindred Biosciences, Inc. | KIN | IPO | $6.00-$8.00 | 7.5 million | 12/12/2014 | Leerink Partners, BMO Capital Markets, Guggenheim Securities |
| Kolltan Pharmaceuticals | KLTN | IPO | TBD | TBD | 0/0/0 | Leerink Partners, Stifel |
| Kyverna Therapeutics Inc. | KYTX | IPO | $20.00-$21.00 | 14.5 million | 2/8/2024 | JP Morgan, Morgan Stanley, Leerink Partners, Wells Fargo |
| Latigo Biotherapeutics, Inc. | LTGO | IPO | $16.00-$18.00 | 19.2 million | 8/7/2026 | Goldman Sachs, Jefferies, Leerink Partners, Guggenheim Securities |
| Lexeo Therapeutics, Inc. | LXEO | IPO | $13.00-$15.00 | 9.1 million | 11/3/2023 | J.P. Morgan, Leerink Partners, Stifel, RBC Capital Markets |
| Lumexa Imaging Holdings, Inc. | LMRI | IPO | $17.00-$20.00 | 25 million | 12/11/2025 | Barclays, J.P. Morgan, Jefferies, Deutsche Bank, Wells Fargo, Leerink Partners, William Blair, Capital One Securities, Fifth Third Securities, Raymond James, PNC Capital Markets, Academy Securities, Loop Capital Markets, R. Seelaus & Co. |
| Maplight Therapeutics Inc. | MPLT | IPO | $17.00-$17.00 | 14.75 million | 10/27/2025 | Morgan Stanley, Jefferies, Leerink Partners, Stifel |
| Maze Therapeutics Inc. | MAZE | IPO | $15.00-$17.00 | 8.75 million | 1/31/2025 | J.P. Morgan, TD Cowen, Leerink Partners, Guggenheim Securities |
| Mersana Therapeutics, Inc. | MRSN | IPO | $14.00-$16.00 | 5 million | 6/28/2017 | J.P. Morgan, Cowen and Company, Leerink Partners |
| Mevion Medical Systems | MEVI | IPO | Withdrawn | Withdrawn | 0/0/0 | Jefferies, Leerink Partners |
| Mirna Therapeutics | MIRN | IPO | $13.00-$15.00 | 6.25 million | 10/1/2015 | Citigroup, Leerink Partners |
| MorphoSys AG | MOR | IPO | $24.12-$24.12 | 8.3 million ADSs | 4/19/2018 | Goldman Sachs & Co., J.P. Morgan, Leerink Partners |
| Nabriva Therapeutics AG | NBRV | IPO | $10.50-$10.50 | 9 million | 9/18/2015 | Leerink Partners, RBC Capital Markets |
| Nightstar Therapeutics Limited | NITE | IPO | $13.00-$15.00 | 5.36 million ADSs | 9/28/2017 | Jefferies, Leerink Partners, BMO Capital Markets |
| ObsEva SA | OBSV | IPO | $14.00-$16.00 | 6.45 million | 1/26/2017 | Credit Suisse, Jefferies, Leerink Partners |
| Parabilis Medicines, Inc. | PBLS | IPO | $17.00-$19.00 | 33.5 million | 6/10/2026 | Leerink Partners, BofA Securities, Evercore ISI, Guggenheim Securities, LifeSci Capital |
| Proqr Therapeutics B.V. | PRQR | IPO | $11.00-$13.00 | 7.5 million | 9/18/2014 | Leerink Partners, Deutsche Bank Securities |
| Protagonist Therapeutics | PTGX | IPO | $12.00-$12.00 | 7.5 million | 8/11/2016 | Leerink Partners, Barclays, BMO Capital Markets |
| Proteostasis Therapeutics | PTI | IPO | $12.00-$14.00 | 6.25 million | 2/11/2016 | Leerink Partners, RBC Capital Markets |
| Replimune Group, Inc. | REPL | IPO | $14.00-$16.00 | 6.7 million | 7/20/2018 | J.P. Morgan, Leerink Partners, BMO Capital Markets |
| resTORbio, Inc. | TORC | IPO | $14.00-$16.00 | 5.67 million | 1/26/2018 | BofA Merrill Lynch, Leerink Partners, Evercore ISI |
| Retension Pharmaceuticals, Inc. | RTSN | IPO | $11.00-$13.00 | 3.75 million | 10/9/2026 | Leerink Partners, Guggenheim Securities, Oppenheimer & Co., Titan Partners |
| Roka Biosciences | ROKA | IPO | $14.00-$16.00 | 5 million | 7/17/2014 | BofA Merrill Lynch, Leerink Partners |
| Rubius Therapeutics, Inc. | RUBY | IPO | $20.00-$22.00 | 10.5 million | 7/18/2018 | J.P. Morgan, Morgan Stanley, Jefferies, Leerink Partners |
| Scribe Therapeutics Inc. | SCTX | IPO | $13.00-$15.00 | 8.58 million | 7/24/2026 | Leerink Partners, Goldman Sachs, Guggenheim Securities, Wells Fargo |
| Seaport Therapeutics, Inc. | SPTX | IPO | $16.00-$18.00 | 14.2 million | 5/1/2026 | Goldman Sachs, J.P. Morgan, Leerink Partners, Citigroup, Stifel
|
| Solid Biosciences Inc. | SLDB | IPO | $18.00-$19.00 | 7.5 million | 1/25/2018 | J.P. Morgan, Goldman Sachs & Co., Leerink Partners |
| SpyGlass Pharma, Inc. | SGP | IPO | $15.00-$17.00 | 9.375 million | 2/6/2026 | Jefferies, Leerink Partners, Citigroup, Stifel |
| Tocagen, Inc. | TOCA | IPO | $10.00-$12.00 | 8.5 million | 4/13/2017 | Leerink Partners, Evercore ISI, Stifel |
| Translate Bio, Inc. | TBIO | IPO | $12.00-$14.00 | 9.4 million | 6/28/2018 | Citigroup, Leerink Partners, Evercore ISI |
| Valeritas, Inc | VLRX | IPO | $14.00-$16.00 | 5 million | 0/0/0 | Piper Jaffray, Leerink Partners
|
| Veradermics, Incorporated | MANE | IPO | $14.00-$16.00 | 15.1 million | 2/4/2026 | Jefferies, Leerink Partners, Citigroup, Cantor |
| Visterra, Inc. | VIST | IPO | $12.00-$14.00 | 3.9 million | 0/0/0 | Leerink Partners, Stifel |
| Wave Life Sciences PTE, Ltd. | WVE | IPO | $15.00-$17.00 | 6.375 million | 11/11/2015 | Jefferies, Leerink Partners |
| Xeris Pharmaceuticals, Inc. | XERS | IPO | $14.00-$16.00 | 5.7 million | 6/21/2018 | Jefferies, Leerink Partners, RBC Capital, Mizuho Securities |
| Zafgen, Inc. | ZFGN | IPO | $14.00-$16.00 | 6 million | 6/19/2014 | Leerink Partners, Cowen and Company
|
| Zai Lab Limited | ZLAB | IPO | $16.00-$18.00 | 8.0 million ADSs | 9/20/2017 | J.P. Morgan, Citigroup, Leerink Partners |
© 2005 - 2026 IPO Boutique. All Rights Reserved